Cardizem, Cardizem CD (diltiazem) dosing, indications, …
https://reference.medscape.com/drug/cardizem-cd-diltiazem-342374
acalabrutinibdiltiazem will increase the level or effect of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Reduce acalabrutinib dose to 100... acebutololacebutolol and diltiazem both increase anti-hypertensive channel blocking. Modify Therapy/Monitor Closely. acalabrutinibdiltiazem will increase the level or effect of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Reduce acalabrutinib dose to 100... acebutololacebutolol and diltiazem both increase anti-hypertensive channel blocking. Modify Therapy/Monitor Closely. aldesleukinaldesleukin increases effects of diltiazem by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension. alfentanildiltiazem will increase the level or effect of alfentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. In patients receiving both diltiazem and alfentani...
acalabrutinibdiltiazem will increase the level or effect of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Reduce acalabrutinib dose to 100...
acebutololacebutolol and diltiazem both increase anti-hypertensive channel blocking. Modify Therapy/Monitor Closely.
aldesleukinaldesleukin increases effects of diltiazem by pharmacodynamic synergism. Use Caution/Monitor. Risk of hypotension.
alfentanildiltiazem will increase the level or effect of alfentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. In patients receiving both diltiazem and alfentani...
DA: 93 PA: 98 MOZ Rank: 97